Haemonetics' quarterly income falls

Haemonetics Corp., which makes automated blood processing systems, today issued a full-year earnings outlook bracketing Wall Street estimates.

The Braintree company said its revenue continues to be affected by sales declines in Japan and it now expects a full-year 2007 adjusted profit of $2.05 to $2.17 per share on revenue growth of 7 to 9 percent. Earnings on a reported basis are seen at $1.62 to $1.76 per share.

Analysts polled by Thomson Financial, on average, expect full-year earnings of $2.08 per share on sales of $455.6 million.

Haemonetics said its third-quarter net income fell to $16.9 million, or 62 cents per share, from $27.9 million, or $1.01 per share, a year ago. Last year's quarter included a 61 cents per share benefit from a nonoperating arbitration award.

Adjusted earnings for the third quarter, excluding certain charges and benefits, were 55 cents per share, according to the company.
(AP)